The medical laser technology market is stratified by application, a primary driver of revenue distribution. Dermatology accounts for roughly 30 % of total sales, reflecting high demand for laser‑based lesion removal, vascular therapy, and skin resurfacing. Ophthalmology follows with 25 %, underpinned by cataract surgery, retinal photocoagulation, and refractive procedures such as LASIK, where precision‑engineered wavelengths command premium pricing. Surgical applications—including general, orthopedic, and neurosurgical laser cutting—contribute 20 %, benefitting from reduced intra‑operative bleeding and faster patient recovery. Dental procedures, encompassing soft‑tissue contouring and hard‑tissue ablation, represent 15 % of market volume, driven by growing adoption of minimally invasive techniques in orthodontics and periodontics. Finally, Cosmetic uses, such as hair removal and tattoo clearance, comprise the remaining 10 %. Collectively, these application segments define the medical laser technology segmentation framework and dictate investment focus across the industry.